Hematology Basic Principles and Practice Eighth Edition
Clinical Manifestations and Treatment of Acute Myeloid Leukemia
Publication
, Chapter
Erba, HP
January 1, 2022
Acute lymphoblastic leukemia (ALL) is a heterogeneous group of diseases characterized by clonal proliferation of lymphoid progenitors (lymphoblasts). Improved diagnostic tools permit accurate and prompt diagnosis, and aid in evaluation of minimal residual disease (MRD). There have been significant advances in the past decade toward understanding disease pathogenesis, refinement of prognostic groups, and the development of exciting new therapies directed toward specific disease subsets. These molecular targeted and immunotherapeutic approaches are transforming the treatment strategies for adults with ALL and are beginning to result in significant improvements in survival.
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Erba, H. P. (2022). Clinical Manifestations and Treatment of Acute Myeloid Leukemia. In Hematology Basic Principles and Practice Eighth Edition (pp. 950–976). https://doi.org/10.1016/B978-0-323-73388-5.00060-2
Erba, H. P. “Clinical Manifestations and Treatment of Acute Myeloid Leukemia.” In Hematology Basic Principles and Practice Eighth Edition, 950–76, 2022. https://doi.org/10.1016/B978-0-323-73388-5.00060-2.
Erba HP. Clinical Manifestations and Treatment of Acute Myeloid Leukemia. In: Hematology Basic Principles and Practice Eighth Edition. 2022. p. 950–76.
Erba, H. P. “Clinical Manifestations and Treatment of Acute Myeloid Leukemia.” Hematology Basic Principles and Practice Eighth Edition, 2022, pp. 950–76. Scopus, doi:10.1016/B978-0-323-73388-5.00060-2.
Erba HP. Clinical Manifestations and Treatment of Acute Myeloid Leukemia. Hematology Basic Principles and Practice Eighth Edition. 2022. p. 950–976.